NCT04571229 2026-03-18
Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
Memorial Sloan Kettering Cancer Center
Available
Clinical Trials
6 trialsNCT03643133 2025-12-26
SARCOME13
UNICANCER
Phase 2 Active not recruiting
NCT01459484 2024-05-20
ISG/OS-2
Italian Sarcoma Group
Phase 2 Completed
NCT02441309 2019-09-13
MEMOS
University of Oxford
Phase 2 Terminated
NCT01194284 2017-01-19
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Takeda
Terminated
NCT00631631 2014-05-14
Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
Millennium Pharmaceuticals, Inc.
Completed